Skip to content

Two Hypoabsorption Techniques for the Treatment of Type III Obesity (OASIS)

Randomized Prospective Study Comparing Two Hypoabsorption Techniques for the Treatment of Type III Obesity (Body Mass Index Between 45 - 49.9 Kg/m2): Single Anastomose Duodenal Switch (SADI-S) and Single Anastomose Gastric By-pass (OAGBP)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05948852
Acronym
OASIS
Enrollment
96
Registered
2023-07-17
Start date
2023-07-31
Completion date
2029-07-31
Last updated
2023-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid

Keywords

OAGB, SADIS, bariatric surgery

Brief summary

This study aims to compare the percentage of total weight lost in long-term follow-up after two surgical interventions (SADIS and OAGB) in patients with morbid obesity BMI between 45-49.9.

Interventions

PROCEDUREmetabolic surgery (SADIS and OAGB)

TWO HYPOABSORPTION TECHNIQUES FOR THE TREATMENT OF TYPE III OBESITY (BODY MASS INDEX BETWEEN 45 - 49.9 KG/M2): SINGLE ANASTOMOSE DUODENAL SWITCH (SADI-S) AND SINGLE ANASTOMOSE GASTRIC BY-PASS (OAGBP).

Sponsors

Consorci Sanitari Integral
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 and under 65 who meet criteria for bariatric surgery. * Maximum BMI between 45 and 50 kg/m2 and indication for surgery in a time * Signature of the informed consent of the study * Patients suitable for laparoscopic surgery

Exclusion criteria

* Previous bariatric surgery * 2-stage surgery * Contraindication for hypoabsorptive surgery due to previous pathology: inflammatory bowel disease, transplant recipient or transplant candidate, previous intestinal resection surgery * Other associated surgical procedures in the same intervention. * Conversion to laparotomy

Design outcomes

Primary

MeasureTime frame
the percentage of total weight loss (%TWL) of the patients after surgeryBaseline, 1 year, 3 year, 5 year after SADI-S and OAGBP surgery

Secondary

MeasureTime frameDescription
Number of deaths in the immediate postoperative periodup to day 90 post-intervention
Number of Participants with complications in the immediate postoperative periodup to day 90 post-intervention
% of patients with gastroesophageal reflux (acid and bile) after surgery1 year, 3 year, 5 year after SADI-S and OAGBP surgery
questionnaire of quality of life1 year, 3 years, 5 years after SADI-S and OAGBP surgeryThe quality of life will be assessed based on the results of the Moorehead-Ardelt II test and the Medical Outcomes Study Short Form-36 questionnaire. The Moorehead-Ardelt II questionnaire includes 6 parameters related to self-esteem, physical activity, social contact, job satisfaction, sexual pleasure, and eating habits. The minimum score is -3 and the maximum is +3. A score of 1.1 to 2 is considered a good result, and anything above 2.1 is considered very good. The SF-36 questionnaire includes 8 parameters such as physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role, and mental health. The minimum score is 0 and the maximum is 100.
Number of patients with nutritional deficiencies1 year, 3 years, 5 years after SADI-S and OAGBP surgeryThe main nutritional deficiencies to be evaluated after OAGB (One Anastomosis Gastric Bypass) and SADIS (Single Anastomosis Duodeno-Ileal Switch) are iron and/or vitamin B12 deficiency anemia, deficiencies in fat-soluble vitamins, calcium, and trace elements. The incidence of nutritional deficiencies will be assessed through routine blood tests at 1 year, 3 years, and 5 years after the surgery
Ratio of patients with more than 3 loose stools per day1 year, 3 years, 5 years after the surgeryThe ratio of patients with more than 3 loose stools per day will be evaluated as pathological. To assess the quality of the bowel movements, the Bristol Stool Form Scale questionnaire will be used. An evaluation of the number of bowel movements and their quality according to the Bristol Stool Form Scale questionnaire will be conducted at 1 year, 3 years, and 5 years after the surgery

Contacts

Primary ContactSergio Sanchez Cordero, MD
Sergi.SanchezCordero@sanitatintegral.org+34 93 553 12 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026